Navigation Links
InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance
Date:10/1/2009

CHO cell culture, including:
 
  • Faster cell line development and seed train expansion
  • Animal component-free
  • Consistency of a defined media component
  • Biomanufacturing optimization and improved production economics
  • Better and more predictable performance in cell culture research and development

"Our product development team created Zap-CHO to exceed the needs of our customers working in CHO cell culture," said Scott Deeter, InVitria's President and CEO. "Our customers have realized exceptional performance results using Zap-CHO. InVitria's products, like Zap-CHO, are creating a new era for the cell culture manufacturing industry."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products or to order, please contact InVitria at info@invitria.com or call 1-800-916-8311. InVitria's products can also be purchased online Click Here.

###

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
2. InVitria Presents Zap-CHO Performance Results at PEACe Conference
3. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
4. InVitria Cell Culture Product Line to Headline PEACe
5. InVitria Sponsors ESACT 2009 in Dublin, Ireland
6. InVitria to Present at BIO 2009 International Convention in Atlanta
7. InVitria Reveals Technology to Optimize Hybridoma Production Performance
8. InVitria Headlines Sponsorship of WilBio's Waterside Conference
9. InVitria Announces Launch of Recombinant Albumin for Diagnostics
10. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
11. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was announced ... been recognised for his outstanding contribution to enhancing the world's production and distribution of ... World Food Prize Foundation, announced this year’s winner at a ceremony at the State ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative ... combo, and compounding pharmacy operations, announces the most recent positioning of SuiteRx CEO, ... RBC event at the Venetian Las Vegas, Nevada. During this event, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning ... Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... years who participated in the National Survey on Drug Use and Health, which ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
... 28 The one-stop marketplace,for the fine and ... take place at SETEC in Seoul, South Korea, ... range of items in these fields, from,ingredients and ... http://www.newscom.com/cgi-bin/prnh/20080728/NYM070 ), Since its launch ...
... Safety Violations, SALINAS, Calif., July 28 Nursing ... Care Center will,hold a joint demonstration Tuesday asking their ... both of these homes made Windsor,owners over $2 million ... eight Bay Area nursing homes operated by Windsor,Healthcare., ...
... millions of Mexican pesos as of December,31, 2007. Comparisons are ... may vary due to rounding practices. "bp" stands,for basis points), ... - Gross income increased 34.45%, - Gross margin ... as a percentage of sales were 7.19%, - The ...
... Isn,t it odd that cancer cells from one organ, such ... totally different organ, like the lung? , What,s more, why ... to certain places? Prostate cancer usually moves to bone; colon ... Hendrik van Deventer, assistant professor of medicine at the University ...
... Laboratories to Improve ... to Care Across the Country, DAR ES SALAAM, Tanzania, July ... Welfare, United Republic,of Tanzania, and Abbott Fund commemorated the latest step ... cornerstone,for the first of 23 hospital laboratories to be built or ...
... Healthcare, Inc.,(OTC Bulletin Board: TONJ), a premier provider ... it has engaged German,based Dr. Petri Hospital Consulting ... in Nanning, China., Previously, the company reported ... now readjusted architectural and operational plans to,incorporate additional ...
Cached Medicine News:Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 2Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 3Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 4Health News:Caregivers at 8 Bay Area Nursing Homes Protest Unsafe Resident Conditions in Salinas 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 3Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 4Health News:Study provides clues to preventing and treating cancer spread 2Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 2Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 3Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 4Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 5Health News:Tongji Hires German Based Dr. Petri Consulting GmbH for Langdong Project 2
(Date:7/1/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... in New York, NY on ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:7/1/2015)... Pa. , July 1, 2015 Precyse, ... and education, announced today that, as part of its ... an agreement to be acquired by investment firm Pamplona ... private equity investors, Altaris Capital Partners and NewSpring Capital, ... in 1999, has assisted nearly 5,000 healthcare facilities and ...
(Date:7/1/2015)... DUBLIN , June 24, 2015 ... has announced the addition of the "2015 ... to their offering. This new 175-page ... market segments, including diabetes (strips and meters), pregnancy, ... dynamics, size, growth, regulatory requirements, technologies, and competitive ...
Breaking Medicine Technology:ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 32015 Strategies in the Home/Self Testing Market 2
... Instruments Incorporated (TI) (NASDAQ: TXN ) today ... with five new fully integrated AFEs for portable biopotential ... AFEs are the first to offer 16- and 24-bit ... power consumption by more than 94 percent compared to ...
... April 4, 2012  UCB (Euronext Brussels: UCB) and Amgen ... of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical ... "We look forward to working with UCB on ... Harper, M.D., executive vice president of Research and Development ...
Cached Medicine Technology:TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 2TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 3TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 4TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 5UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 2UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 3UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 4UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 5UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 6UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 7
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: